2023 Symposium Supporters

At Recordati Rare Diseases, we are “Focused on the few”, with a mission to reduce the impact of rare and devastating diseases by providing urgently needed therapies. Recordati Rare Diseases is focused on providing the most effective treatment for people living with rare diseases and has formed part of the Recordati Group since 2007.

Recordati is uniquely structured to bring treatment options across a range of therapeutic areas and fully integrated operations across research & development, chemical and finished product manufacturing through to commercialisation and licensing. We believe that health, and the opportunity to live life to the fullest, is a right, not a privilege. We want to give people the opportunity to unlock the full potential of life.

Y-mAbs is a late-stage clinical, global biopharmaceutical company specializing in developing antibody-based products to treat challenging pediatric cancers, and ultimately adult patients.

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and
life-threatening conditions. As a group, we are relentless in our pursuit of
“medicines for life” and continue to research and develop treatments for
cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases.

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives.

Our teams across the world strive to transform the practice of medicine, turning the impossible into the possible for patients.

We provide potentially life-changing treatments and the protection of life-saving vaccines to millions of people, and affordable access to our medicines in some of the world’s poorest countries.

US WorldMeds is a specialty pharmaceutical company that develops, licenses, and brings to market unique healthcare products designed to improve the lives of patients with challenging conditions and unmet medical needs.

We will develop, license, and market meaningful and accessible healthcare products that improve lives and result in a thriving community of patients, employees, and shareholders.